CBLL — CeriBell, Inc. stock price, charts and financials

QT53CeriBell, Inc.

CeriBell, Inc. (NASDAQ: CBLL) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
19.30
+0.49+2.60%
OverviewShort InterestFilings
CBLLQT53CeriBell, Inc.·NASDAQ
19.30+2.60%
Earnings
Up 2.6% — Reported earnings — EPS missed by 33%, revenue beat by 2%.
High confidence
TA
Loading chart...
Signal & projected range
Insider open-market saleHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
BBNX+3.14%$16.40SSII-1.06%$3.73TCMD-1.22%$29.14AHCO-8.26%$5.22BWAY-1.16%$15.32SIBN+1.24%$18.84AVR+0.56%$8.96KIDS+2.24%$23.28
Snapshot
Index-P/E-EPS (ttm)-1.63Insider Own23.22%Shs Outstand37.94MPerf Week6.33%
Market Cap713.70MForward P/E-EPS next Y-1.15Insider Trans-5.09%Shs Float24.72MPerf Month-4.23%
Enterprise Value690.57MPEG-EPS next Q-Inst Own-Short Float7.47%Perf Quarter-7.70%
Income-60.81MP/S7.51EPS this Y-4.72%Inst Trans-Short Ratio5.57Perf Half Y-2.74%
Sales95.07MP/B5.03EPS next Y32.82%ROA-33.90%Short Interest1.85MPerf YTD-14.23%
Book/sh-P/C-EPS next 5Y-ROE-38.19%52W High24.96 -22.69%Perf Year47.18%
Cash/sh-P/FCF-EPS past 3/5Y-ROIC-39.83%52W Low11.13 73.36%Perf 3Y-
Dividend Est.-EV/EBITDA-Sales past 3/5Y50.71% -Gross Margin87.72%Volatility3.20% 4.13%Perf 5Y-
Dividend TTM-EV/Sales7.26EPS Y/Y TTM51.92%Oper. Margin-68.31%ATR (14)0.76Perf 10Y-
Dividend Ex-Date-Quick Ratio9.87Sales Y/Y TTM46.15%Profit Margin-63.51%RSI (14)54.83Recom2.00
Dividend Gr. 3/5Y-Current Ratio10.30EPS Q/Q-44.44%SMA203.51%Beta1.33Target Price25.00
Payout0.00%Debt/Eq0.16Sales Q/Q30.00%SMA501.63%Rel Volume0.63Prev Close18.81
Employees327LT Debt/Eq0.14EarningsAug 10SMA2001.01%Avg Volume362.35KPrice19.30
IPO DateOct 11, 2024Option/ShortYes / YesEPS/Sales Surpr.-33.07% 1.57%Net Debt/EBITDA0.40Volume229,479Change2.60%
Analyst Ratings
DateActionAnalystRatingTarget
May-12-26ReiteratedCanaccord GenuityBuy$30 → $25
Dec-15-25ReiteratedBTIGBuy$30
Nov-05-24ReiteratedCanaccord Genuity$30
Latest News
Company

CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
Total Revenue958965——
Cost of Goods Sold Incl. D&A12119——
Gross Profit847857——
Selling, General and Administrative Excl. Other12811883——
Research and Development211914——
Other Operating Expense00-1——
Operating Income-66-58-40——
Interest Expense022——
Unusual Expense
—————
Non-Operating Income (Expense)771——
Net Income Before Taxes-61-53-40——
Income Taxes
000——
Consolidated Net Income-61-53-40——
Net Income From Continuing Operations-61-53-40——
Net Income-61-53-40——
EPS (Recurring)-1.63-1.46-3.39——
EPS (Basic, Before Extraordinaries)-1.63-1.46-3.39——
EPS (Diluted)-1.63-1.46-3.39——
EBITDA-58-50-37——
Other After Tax Adjustments
—————
Stock Option Compensation Expense
—————
Price To Earnings Ratio
—————
Price To Sales Ratio7.729.124.78——
Gross Margin88.4287.6487.69——
Operating Margin-69.47-65.17-61.54——
Net Margin-64.21-59.55-61.54——
Shares Outstanding383712——
Market Capitalization733811311——
Operating Lease Expense
—————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$25.31$21.24$17.18$13.11$9.04● Close Price0.00M1.16M2.32M3.49M4.65MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Chao XingjuanPresident and CEOAug 03 '26Option Exercise4.7025,000117,500827,317Aug 05
Chao XingjuanPresident and CEOAug 03 '26Sale18.3239,000714,480788,317Aug 05
Chao XingjuanPresident and CEOJul 07 '26Option Exercise4.7025,000117,500825,871Jul 09
Chao XingjuanPresident and CEOJul 07 '26Sale19.9023,554468,725802,317Jul 09
BURKE WILLIAM WDirectorJun 30 '26Sale19.842,20743,78723,022Jul 02
TPG GP A, LLCother: Former 10% OwnerJun 26 '26Sale20.12202,3684,071,7053,765,054Jun 30
Taylor Joseph MichaelDirectorJun 11 '26Sale18.415,500101,25561,573Jun 15
Chao XingjuanPresident and CEOJun 08 '26Option Exercise4.7025,000117,500839,871Jun 10
Chao XingjuanPresident and CEOJun 08 '26Sale18.3323,554431,745816,317Jun 10
Foehr DavidSenior VP, Finance and PAOMay 22 '26Sale18.8086216,20637,751May 26
Manni Joseph S.Chief Revenue OfficerMay 21 '26Sale18.001,37824,80456,291May 26
Foehr DavidSenior VP, Finance and PAOMay 21 '26Sale18.0098717,76638,613May 26
Woo RaymondChief Technology OfficerMay 21 '26Sale18.001,96635,388195,682May 26
Blumberg ScottChief Financial OfficerMay 21 '26Sale18.001,38724,966147,683May 26
Chao XingjuanPresident and CEOMay 21 '26Sale18.006,030108,540830,317May 26
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.